Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherCellular and Molecular

Inhibition of AP-1 by barbiturates is mediated by differential effects on MAP-kinases and the small G proteins Ras and Rac-1

Matjaz Humar, Nikolaos Andriopoulos, Soeren Erik Pischke, Torsten Loop, Rene Schmidt, Alexander Hoetzel, Martin Roesslein, Heike Luise Pahl, Klaus Klemens Geiger and Benedikt Heinrich-Johannes Pannen
Journal of Pharmacology and Experimental Therapeutics July 19, 2004, DOI: https://doi.org/10.1124/jpet.104.071332
Matjaz Humar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaos Andriopoulos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soeren Erik Pischke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torsten Loop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rene Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Hoetzel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Roesslein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heike Luise Pahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Klemens Geiger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedikt Heinrich-Johannes Pannen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 368 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 368, Issue 3
1 Mar 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of AP-1 by barbiturates is mediated by differential effects on MAP-kinases and the small G proteins Ras and Rac-1
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
Citation Tools
OtherCellular and Molecular

Inhibition of AP-1 by barbiturates is mediated by differential effects on MAP-kinases and the small G proteins Ras and Rac-1

Matjaz Humar, Nikolaos Andriopoulos, Soeren Erik Pischke, Torsten Loop, Rene Schmidt, Alexander Hoetzel, Martin Roesslein, Heike Luise Pahl, Klaus Klemens Geiger and Benedikt Heinrich-Johannes Pannen
Journal of Pharmacology and Experimental Therapeutics July 19, 2004, DOI: https://doi.org/10.1124/jpet.104.071332

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherCellular and Molecular

Inhibition of AP-1 by barbiturates is mediated by differential effects on MAP-kinases and the small G proteins Ras and Rac-1

Matjaz Humar, Nikolaos Andriopoulos, Soeren Erik Pischke, Torsten Loop, Rene Schmidt, Alexander Hoetzel, Martin Roesslein, Heike Luise Pahl, Klaus Klemens Geiger and Benedikt Heinrich-Johannes Pannen
Journal of Pharmacology and Experimental Therapeutics July 19, 2004, DOI: https://doi.org/10.1124/jpet.104.071332
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Loss of Endothelial Cell–Specific PPARγ Blocks ROSI-Induced Edema
  • Targeting thioredoxin reductase by ibrutinib promotes apoptosis of SMMC-7721 cells
  • Synthetic Cannabinoid Hydroxypentyl Metabolite Pharmacology
Show more Cellular and Molecular

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics